Whole rat DNA array survey for candidate genes related to hypertension in kidneys from three spontaneously hypertensive rat substrains at two stages of age and with hypotensive induction caused by hydralazine hydrochloride

Experimental and Therapeutic Medicine

Volumn 2, Issue 2, 2011, Pages 201-212

  Kinoshita, Kosho ^a   Ashenagar, Mohammad Said ^a   Tabuchi, Masaki ^a   Higashino, Hideaki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA array; Hydralazine; Hypertension; Kidney; Malignant type of stroke prone spontaneously hypertensive rat; Spontaneously hypertensive rat; Stroke prone spontaneously hypertensive rat

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE TRIPHOSPHATASE; ANNEXIN; ANNEXIN A13; BETA CATENIN; CADHERIN; CELL MEMBRANE PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME; CYTOCHROME P450 2C; CYTOCHROME P450 CYP8B1; DUAL SPECIFICITY PHOSPHATASE 15; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 2; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 1B; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN 4; HYDRALAZINE; METHYLTRANSFERASE; METHYLTRANSFERASE LIKE 2; MITOGEN ACTIVATED PROTEIN KINASE 14; PHOSPHATASE; PROTEIN ARMC3; PROTEIN ATP12A; PROTEIN KINASE; PROTEIN VNN1; PROTIN PRKAR2B; PROTOCADHERIN 9; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; MALIGNANT TYPE STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RAT STRAIN; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

EID: 79551635257     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.193     Document Type: Article

References (39)

1. Acelajado MC and Oparil S: Hypertension in the elderly. Clin Geriatr Med 25: 391-412, 2009.
2. Ghiadoni L, Bruno RM, Stea F, Virdis A and Taddei S: Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essential hypertension. Curr Hypertens Rep 11: 190-196, 2009.
3. Kannel WB: Table of contents. Hypertension: reflections on risks and prognostication. Med Clin North Am 93: 541-558, 2009.
4. Imaizumi Y: Mortality in the elderly population aged over 40 in Japan, 1947-1988. Jinko Mondai Kenkyu (in Japanese) 47: 40-57, 1991.
5. Kesteloot H, Yuan XY and Joossens JV: Changing mortality patterns in men. Acta Cardiol 43: 133-139, 1988.
6. Drmanac R, Drmanac S, Strezoska Z, et al: DNA sequence determination by hybridization: a strategy for efficient large-scale sequencing. Science 260: 1649-1652, 1993.
7. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E and Davis RW: Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol 16: 301-306, 1998.
8. Hacia JG, Brody LC and Collins FS: Applications of DNA chips for genomic analysis. Mol Psychiatry 3: 483-492, 1998.
9. McBride MW, Charchar FJ, Graham D, et al: functional genomics in rodent models of hypertension. J Physiol 554: 56-63, 2004.
10. Okamoto K and Aoki K: Development of a strain of spontaneously hypertensive rat. Jpn Circ J 27: 282-293, 1963.
11. Okamoto K, Yamori Y and Nagaoka A: establishment of the stroke-prone spontaneously hypertensive rats (SHR). Circ Res 34 (Suppl 1): 143-153, 1974.
12. Okamoto K, Yamamoto K, Morita N and Ohta Y: establishment and characteristics of rat with precocious and severe hypertension (M-SHRSP). Acta Med Kinki Univ 10: 73-95, 1985.
13. Ashenagar MS, Tabuchi M, Kinoshita K, et al: Gene expression in the adrenal glands of three spontaneously hypertensive rat substrains. Mol Med Rep 3: 213-222, 2010.
14. Guyton AC: Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens 2: 575-585, 1989.
15. Guyton AC: Abnormal renal function and autoregulation in essential hypertension. Hypertension 18 (Suppl 5): 49-53, 1991.
16. Gavras H, Brunner HR and Laragh JH: Renin and aldosterone and the pathogenesis of hypertensive vascular damage. Prog Cardiovasc Dis 17: 39-49, 1974.
17. Satoh T, Owada S and Ishida M: Recent aspects in the genetic renal mechanisms involved in hypertension. Intern Med 38: 919-926, 1999.
18. Ely D, Milsted A, Dunphy G, et al: Delivery of sry1, but not sry2, to the kidney increases blood pressure and SNS indices in normotensive WKY rats. BMC Physiol 9: 10, 2009.
19. Graham D, McBride MW, Gaasenbeek M, et al: Candidate genes that determine response to salt in the stroke-prone spontaneously hypertensive rat: congenic analysis. Hypertension 50: 1134-1141, 2007.
20. Kreutz R, Schulz A, Sietmann A, Stoll M, Daha MR, de Heer E and Wehland M: Induction of C1q expression in glomerular endothelium in a rat model with arterial hypertension and albu-minuria. J Hypertens 25: 2308-2316, 2007.
21. Clemitson JR, Dixon RJ, Haines S, et al: Genetic dissection of a blood pressure quantitative trait locus on rat chromosome 1 and gene expression analysis identifies SPON1 as a novel candidate hypertension gene. Circ Res 100: 992-999, 2007.
22. McBride MW, Brosnan MJ, Mathers J, et al: Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension 45: 786-792, 2005.
23. Zhong JC, Huang DY, Yang YM, Li YF, Liu GF, Song XH and Du K: Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 44: 907-912, 2004.
24. Kurdi M, Cerutti C, Randon J, McGregor L and Bricca G: Macroarray analysis in the hypertrophic left ventricle of renin-dependent hypertensive rats: identification of target genes for renin. Renin Angiotensin Aldosterone Syst 5: 72-78, 2004.
25. Seubert JM, xu F, Graves JP, et al: Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats. Am J Renal Physiol 289: F552-F561, 2005.
26. Charchar FJ, Kaiser M, Bingham AJ, Fotinatos N, Ahmady F, Tomaszewski M and Samani NJ: Whole genome survey of copy number variation in the spontaneously hypertensive rat: relationship to quantitative trait loci, gene expression, and blood pressure. Hypertension 55: 1231-1238, 2010.
27. Simon R, Lam A, Li M-C, et al: Analysis of gene expression data using BRB-array tools. Cancer Informatics 3: 11-17, 2007.
28. Altschul SF, Thomas LM, Alejandro AS, et al: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1977.
29. Toal C and Leenen FH: Dietary sodium restriction and development of hypertension in spontaneously hypertensive rats. Am J Physiol 245: H1081-H1084, 1983.
30. Wexler BC: Inhibition of the pathogenesis of spontaneous hypertension in spontaneously hypertensive rats by feeding a high fat diet. endocrinology 108: 981-989, 1981.
31. Okamoto K, Ohta Y, Chikugo T, Shiokawa H and Morita N: Chronic treatment with captopril, SQ29,852, hydralazine and a 33% fish meal diet in malignant stroke-prone spontaneously hypertensive rats. J Hypertens 9: 1105-1117, 1991.
32. Yamori Y: Implication of hypertensive rat models for primordial nutritional prevention of cardiovascular diseases. Clin Exp Pharmacol Physiol 26: 568-572, 1999.
33. Pravenec M and Kurtz TW: Recent advances in genetics of the spontaneously hypertensive rat. Curr Hypertens Rep 12: 5-9, 2010.
34. Cowley AW Jr, Roman RJ and Jacob HJ: Application of chromosomal substitution techniques in gene-function discovery. J Physiol 554: 46-55, 2004.
35. Fornage M, Hinojos CA, Nurowska BW, Boerwinkle E, Hammock BD, Morisseau CHP and Doris PA: Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats. Hypertension 40: 485-490, 2002.
36. Corenblum MJ, Wise VE, Georgi K, Hammock BD, Doris PA and Fornage M: Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat. Hypertension 51: 567-573, 2008.
37. Chiamvimonvat N, Ho CM, Tsai HJ and Hammock BD: The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol 50: 225-237, 2007.
38. Li J, Carroll MA, Chander PN, Falck JR, Sangras B and Stier CT: Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension. Front Biosci 13: 3480-3487, 2008.
39. Yousif MH and Benter IF: Role of 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of vascular function in a model of hypertension and endothelial dysfunction. Pharmacology 86: 149-156, 2010.